GHX Europe

GHX Europe

Private
BelgiumEnterprise Softwarehttps://www.ghx.com/europe/

Last Round

Private Equity

1/8/2026

Total Funding Raised

$500M

Company Overview

GHX Europe is the European division of Global Healthcare Exchange (GHX), a technology company that provides cloud-based supply chain management solutions for the healthcare industry. Founded in 2000, GHX operates the largest healthcare trading network, connecting providers, suppliers, distributors, and other stakeholders to streamline business processes. The company's mission is to simplify the patient-centered business of healthcare to improve outcomes and reduce costs. Its platform automates processes like order management, procurement, invoicing, and payments, and provides data and analytics to improve efficiency. GHX is majority-owned by Temasek, with a minority stake held by Warburg Pincus. The European headquarters is in Brussels, Belgium, with additional offices in the UK, Germany, Switzerland, and the Netherlands.

Sector

Enterprise Software

Verticals

Supply Chain, Vertical SaaS, Workflow Automation, Logistics Software, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Payment Processing Fee, Data as a Service, Government Contracts

AI Layer

Application

Keywords

healthcare supply chainsupply chain automationprocure-to-payP2P automationorder-to-cashO2C automatione-invoicingPeppol access pointelectronic trading platformhealthcare procurementhealthtechproduct information managementPIMitem master datadata cleansingB2B SaaS platformERP integrationGPO solutions

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GHX Europe Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GHX Europe Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Private Equity1/8/2026
Growth Equity6/2/2021
Buyout/LBO7/13/2017
Buyout/LBO3/11/2014
Corporate Funding3/29/2000

GHX Europe Investors

Notable investors and investment history

InvestorRounds
TemasekPrivate Equity
Veritas CapitalPrivate Equity
GE HealthCareCorporate Funding
Warburg PincusPrivate Equity, Growth Equity
MedtronicCorporate Funding
Thoma BravoBuyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 4, 2026

    Partnerships include Workday, Oracle, SAP, and Infor.

  • Mar 3, 2026

    Enables over $1 billion in annual savings for the healthcare community.

GHX Europe Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GHX Europe Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GHX Europe's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Year Founded2000
Last Funding1/8/2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.